Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.

Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. J Clin Oncol. 2006 Sep 01; 24(25):4196-201.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Agents, Alkylating
Chemotherapy, Cancer, Regional Perfusion
Extremities
Female
Humans
Hyperthermia, Induced
Male
Melanoma
Melphalan
Middle Aged
Patient Selection
Skin Neoplasms
Treatment Outcome
Tumor Necrosis Factor-alpha
United States

authors with profiles

JEFFREY E LEE
PAUL F MANSFIELD
MERRICK I ROSS